{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T20:34:06Z","timestamp":1775853246982,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.contraception.2012.08.039","type":"journal-article","created":{"date-parts":[[2012,10,4]],"date-time":"2012-10-04T03:01:22Z","timestamp":1349319682000},"page":"273-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Added health benefits of the levonorgestrel contraceptive intrauterine system and other hormonal contraceptive delivery systems"],"prefix":"10.1016","volume":"87","author":[{"given":"Ian S.","family":"Fraser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.08.039_bb0005","article-title":"Contraceptive technology: past, present and future","author":"Sitruk-Ware","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/15287397709529554","article-title":"History of the first oral contraceptive","volume":"3","author":"Drill","year":"1977","journal-title":"J Toxicol Environ Health"},{"key":"10.1016\/j.contraception.2012.08.039_bb0015","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/bmj.1.5179.1103","article-title":"Treatment of functional menstrual disorders with norethisterone","volume":"9","author":"Bishop","year":"1960","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2012.08.039_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00003081-198203000-00008","article-title":"Treatment of hyperplasia and carcinoma of the endometrium","volume":"25","author":"Kistner","year":"1982","journal-title":"Clin Obstet Gynecol"},{"issue":"6 II","key":"10.1016\/j.contraception.2012.08.039_bb0025","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0002-9378(16)32492-9","article-title":"Noncontraceptive health benefits of oral steroidal contraceptives","volume":"142","author":"Mishell","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0030","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ajog.2004.01.061","article-title":"Safety concerns and health benefits associated with oral contraception","volume":"190","author":"Burkman","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"4 suppl","key":"10.1016\/j.contraception.2012.08.039_bb0035","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.ajog.2011.06.057","article-title":"The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives","volume":"205","author":"Shulman","year":"2011","journal-title":"AJOG"},{"key":"10.1016\/j.contraception.2012.08.039_bb0040","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/humupd\/dmi019","article-title":"Non-contraceptive health benefits of combined oral contraception","volume":"11","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2012.08.039_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.contraception.2010.04.006","article-title":"Factors affecting mortality in a large cohort study with special reference to oral contraceptive use","volume":"82","author":"Vessey","year":"2010","journal-title":"Contraception"},{"issue":"Suppl. 6","key":"10.1016\/j.contraception.2012.08.039_bb0050","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.contraception.2006.12.013","article-title":"The promise and reality of the intrauterine route for hormone delivery for prevention and therapy of gynecological disease","volume":"75","author":"Fraser","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0055","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.contraception.2010.05.005","article-title":"Non-contraceptive health benefits of intrauterine health systems","volume":"82","author":"Fraser","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0060","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1586\/17434440.5.4.437","article-title":"Levonorgestrel-releasing intrauterine system: uses and controversies","volume":"5","author":"Bahamondes","year":"2008","journal-title":"Expert Rev Med Dev"},{"issue":"4 suppl","key":"10.1016\/j.contraception.2012.08.039_bb0065","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.ajog.2011.04.033","article-title":"The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives","volume":"205","author":"Burke","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0412.2011.01303.x","article-title":"Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS)","volume":"91","author":"Heikinheimo","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2012.08.039_bb0075","first-page":"221","article-title":"The levonorgestrel-releasing IUD","volume":"19","author":"Luukkainen","year":"1993","journal-title":"Br J Fam Plan"},{"key":"10.1016\/j.contraception.2012.08.039_bb0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.contraception.2004.02.005","article-title":"Assessment of menstrual blood loss in women with ideopathic menorrhagia using the frameless levonorgestrel-releasing intrauterine system","volume":"70","author":"Wildemeersch","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0085","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2004.12.004","article-title":"Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system","volume":"71","author":"Wildemeersch","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1086\/418650","article-title":"Women's reproductive cancers in evolutionary context","volume":"69","author":"Eaton","year":"1994","journal-title":"Quart Rev Biol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0095","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1471-0528.1990.tb16240.x","article-title":"Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia","volume":"97","author":"Andersson","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0100","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3109\/00016340903322776","article-title":"Levonorgestrel-IUD should be offered before hysterectomy for abnormal uterine bleeding without uterine structural abnormalities: there are no more excuses!","volume":"88","author":"Dueholm","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2012.08.039_bb0105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/11598960-000000000-00000","article-title":"The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a risk\u2013benefit review","volume":"72","author":"Kaunitz","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.contraception.2012.08.039_bb0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.contraception.2010.06.011","article-title":"Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial","volume":"83","author":"Shabaan","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0115","first-page":"340","article-title":"A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia","volume":"31","author":"Endrikat","year":"2009","journal-title":"JOGC"},{"key":"10.1016\/j.contraception.2012.08.039_bb0120","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/AOG.0b013e3181ff731e","article-title":"Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial","volume":"116","author":"Chelmow","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.contraception.2012.08.039_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003855.pub2","article-title":"Surgery versus medical therapy for heavy menstrual bleeding","author":"Marjoribanks","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.08.039_bb0130","series-title":"Long-acting reversible contraception","author":"National Institute for Health Clinical Excellence","year":"2005"},{"key":"10.1016\/j.contraception.2012.08.039_bb0135","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/AOG.0b013e3182118ac3","article-title":"Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest","volume":"117","author":"Jensen","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0140","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/der224","article-title":"Effective treatment of heavy and\/or prolonged menstrual bleeding with an oral contraceptive containing oestradiol valerate and dienogest: a randomised, double-blind and placebo-controlled phase III trial","volume":"26","author":"Fraser","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.08.039_bb0145","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/AOG.0b013e3181a1d3ce","article-title":"Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis","volume":"113","author":"Kaunitz","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"6 suppl","key":"10.1016\/j.contraception.2012.08.039_bb0150","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.contraception.2007.01.012","article-title":"Progestin-releasing intrauterine systems and leiomyoma","volume":"75","author":"Kaunitz","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0155","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0010-7824(02)00522-X","article-title":"The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia","volume":"67","author":"Mercorio","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0160","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0015-0282(03)00175-4","article-title":"Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas","volume":"79","author":"Grigorieva","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.039_bb0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000080932","article-title":"The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial","volume":"59","author":"Soysal","year":"2005","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.contraception.2012.08.039_bb0170","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"Sayed","year":"2011","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.contraception.2012.08.039_bb0175","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.contraception.2006.11.004","article-title":"Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas","volume":"75","author":"Magalh\u00e3es","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0180","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0015-0282(02)04913-0","article-title":"Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia","volume":"79","author":"Xiao","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.039_bb0185","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijgo.2007.01.009","article-title":"Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia","volume":"97","author":"Kriplani","year":"2007","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.contraception.2012.08.039_bb0190","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0015-0282(97)00245-8","article-title":"Treatment of adenomyosis-associated menorrhagia with a levonorgestrel- releasing intrauterine device","volume":"68","author":"Fedele","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.039_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.contraception.2007.05.091","article-title":"Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging","volume":"76","author":"Bragheto","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0200","doi-asserted-by":"crossref","first-page":"373.e1","DOI":"10.1016\/j.ajog.2007.10.798","article-title":"Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis","volume":"198","author":"Cho","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0010-7824(99)00075-X","article-title":"Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system","volume":"60","author":"Fong","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2008.11.004","article-title":"The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis","volume":"79","author":"Sheng","year":"2009","journal-title":"Contraception"},{"issue":"6 suppl","key":"10.1016\/j.contraception.2012.08.039_bb0215","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.contraception.2007.01.005","article-title":"Levonorgestrel intrauterine system: bleeding disorders and anticoagulant therapy","volume":"75","author":"Kadir","year":"2007","journal-title":"Contraception"},{"issue":"12","key":"10.1016\/j.contraception.2012.08.039_bb0220","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1471-0528.2004.00305.x","article-title":"The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders","volume":"111","author":"Kingman","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2012.08.039_bb0225","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ajog.2005.05.002","article-title":"The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders","volume":"193","author":"Schaedel","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0230","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.fertnstert.2007.07.1315","article-title":"Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders","volume":"90","author":"Lukes","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.039_bb0235","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jmig.2009.04.018","article-title":"The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy","volume":"16","author":"Vilos","year":"2009","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0240","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2009.04.008","article-title":"Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review","volume":"80","author":"Culwell","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0245","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.contraception.2010.07.010","article-title":"Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up","volume":"83","author":"Chi","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0250","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejogrb.2010.08.017","article-title":"A 60-month non-comparative study on bleeding profiles with the levonorgestrel intrauterine system from the late transition period to estrogen supplemented menopause","volume":"153","author":"Depypere","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0255","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jmig.2010.09.013","article-title":"The levonorgestrel intrauterine system is an effective treatment in selected obese women with abnormal uterine bleeding","volume":"18","author":"Vilos","year":"2011","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0260","first-page":"271","article-title":"The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)","volume":"54","author":"Imperato","year":"2002","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0265","first-page":"158","article-title":"Investigation on the prevalence and influencing factors to anemia in women at reproductive age","volume":"20","author":"Wang","year":"1999","journal-title":"Chung-Hua Liu Hsing Ping Hsueh Tsa Chih Chin J Epidemiol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0270","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejogrb.2008.02.022","article-title":"The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia \u2014 a long-term follow-up study","volume":"139","author":"Varma","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0275","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2008.06.014","article-title":"Treatment results of endometrial hyperplasia after prospective D-score classification. A follow-up study comparing effect of LNG-IUD and oral progestins versus observation only","volume":"111","author":"\u00d8rbo","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0280","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1158\/0008-5472.CAN-05-4321","article-title":"Regression of latent endometrial precancers by progestin infiltrated intrauterine device","volume":"66","author":"\u00d8rbo","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.contraception.2012.08.039_bb0285","first-page":"580","article-title":"Levonorgestrel-releasing intrauterine system (Mirena\u00ae) as a therapy for endometrial hyperplasia and carcinoma","volume":"82","author":"Bahamondes","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2012.08.039_bb0290","first-page":"316","article-title":"The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review","volume":"49","author":"Buttini","year":"2009","journal-title":"ANZJOG"},{"key":"10.1016\/j.contraception.2012.08.039_bb0295","doi-asserted-by":"crossref","first-page":"547.e1","DOI":"10.1016\/j.ajog.2010.07.037","article-title":"Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis","volume":"203","author":"Gallos","year":"2010","journal-title":"AJOG"},{"key":"10.1016\/j.contraception.2012.08.039_bb0300","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/13697137.2011.579650","article-title":"The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review","volume":"14","author":"Wan","year":"2011","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2012.08.039_bb0305","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2009.06.014","article-title":"Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system. Long-term follow-up of a randomised control trial","volume":"114","author":"Gardner","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0310","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(99)00291-5","article-title":"A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study","volume":"72","author":"Vercellini","year":"1999","journal-title":"Fertil Steril"},{"issue":"6 suppl","key":"10.1016\/j.contraception.2012.08.039_bb0315","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/j.contraception.2006.12.008","article-title":"Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea","volume":"75","author":"Bahamondes","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0320","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh869","article-title":"Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis","volume":"20","author":"Petta","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.08.039_bb0325","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/157488710792007301","article-title":"Mirena intrauterine system: does it improve long-term symptoms in women with chronic pelvic pain and\/or endometriosis after laparoscopy? A multicentre randomized controlled trial","volume":"5","author":"Alhamdan","year":"2010","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.contraception.2012.08.039_bb0330","first-page":"497","article-title":"Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis","volume":"56","author":"Matorras","year":"2011","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2012.08.039_bb0335","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.fertnstert.2010.08.042","article-title":"Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue","volume":"95","author":"Bayoglu Tekin","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.039_bb0340","first-page":"716","article-title":"Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use","volume":"78","author":"R\u00f6nnerdag","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2012.08.039_bb0345","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejogrb.2010.07.040","article-title":"Acceptability of the levonorgestrel intrauterine system in the long-term treatment of heavy menstrual bleeding: how many women choose to use a second device?","volume":"154","author":"Lete","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0350","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(00)03615-1","article-title":"Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial","volume":"357","author":"Hurskainen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.08.039_bb0355","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/bmj.38376.505382.AE","article-title":"Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002\u20133","volume":"330","author":"Reid","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2012.08.039_bb0360","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3109\/00016340903297150","article-title":"The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial","volume":"88","author":"Heli\u00f6vaara-Peippo","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2012.08.039_bb0365","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.fertnstert.2010.10.009","article-title":"Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis","volume":"95","author":"Ozdegirmenci","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.039_bb0370","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/09513590902972034","article-title":"The levonorgestrel intrauterine system as an alternative to hysterectomy for the treatment of idiopathic menorrhagia","volume":"25","author":"Go\u00f1i","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0375","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/blood-2011-07-366120","article-title":"Ironing out fatigue","volume":"118","author":"Von Drygalski","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2012.08.039_bb0380","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0015-0282(03)00608-3","article-title":"Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.039_bb0385","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/AOG.0b013e31824264c3","article-title":"Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial","volume":"119","author":"Tanmahasamut","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0390","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.contraception.2008.12.001","article-title":"A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents","volume":"79","author":"Paterson","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.039_bb0395","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1471-0528.2009.02372.x","article-title":"The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities","volume":"117","author":"Pillai","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2012.08.039_bb0400","first-page":"247","article-title":"Simultaneous use of a levonorgestrel intrauterine system and an etonogestrel subdermal implant for debilitating adolescent endometriosis","volume":"47","author":"Al-Jefout","year":"2007","journal-title":"ANZJOG"},{"key":"10.1016\/j.contraception.2012.08.039_bb0405","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.1982.tb01625.x","article-title":"Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD","volume":"17","author":"Nilsson","year":"1982","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.contraception.2012.08.039_bb0410","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.fertnstert.2007.08.074","article-title":"Effects of hormonal treatment on nerve fibres in endometrium and myometrium of women with endometriosis","volume":"90","author":"Tokushige","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.039_bb0415","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.fertnstert.2008.07.1774","article-title":"Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis","volume":"92","author":"Tokushige","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.039_bb0420","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1783\/0000000052972799","article-title":"Treatment of pelvic endometriosis with the etonogestrel subdermal implant (Implanon)","volume":"31","author":"Yisa","year":"2005","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.08.039_bb0425","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0010-7824(00)00100-1","article-title":"A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings","volume":"61","author":"Fraser","year":"2000","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412008050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412008050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:45:10Z","timestamp":1761432310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412008050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0010782412008050"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.08.039","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Added health benefits of the levonorgestrel contraceptive intrauterine system and other hormonal contraceptive delivery systems","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2012.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}